Menu
ETF
Annual · values2025202420232022
Operating Cash Flow369.00 M USD1.19 B USD1.92 B USD1.68 B USD
Depreciation & Amortization489.00 M USD555.00 M USD561.00 M USD578.00 M USD
Stock-Based Compensation161.00 M USD112.00 M USD39.00 M USD37.00 M USD
Capital Expenditures379.00 M USD380.00 M USD290.00 M USD251.00 M USD
Cash Flow from Investing2.80 B USD-380.00 M USD-230.00 M USD-253.00 M USD
Cash Flow from Financing-3.06 B USD-240.00 M USD-1.55 B USD-1.46 B USD
Dividends Paid
Stock Buybacks
Free Cash Flow-10.00 M USD805.00 M USD1.63 B USD1.43 B USD

Solventum Corporation is a healthcare company that develops, manufactures, and commercializes solutions leveraging material science, data science, and digital capabilities to address customer and patient needs. It operates through three primary segments: MedSurg, which provides wound therapy, I.V. site management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and OEM medical technologies; Dental Solutions, offering dental and orthodontic products such as brackets, restorative cements, and bonding agents; and Health Information Systems, delivering software solutions including physician documentation, coding automation, speech recognition, and data visualization platforms. The company serves markets in the United States, where it generates the majority of its revenue, and internationally, focusing on medical instruments and supplies within the healthcare sector. Founded in 2023 and headquartered in Eagan, Minnesota, Solventum Corporation plays a key role in advancing healthcare innovations for medical professionals and patients.